MOXIKIND-CV

Indications

• Dry eye conditions
• Tear deficiency
• Keratoconjunctivitis sicca

Dosage

Children: Apply as required, typically in the form of eye drops.

Adults: Apply as required, typically in the form of eye drops.

Mechanism of action

Hypromellose acts by forming a viscous gel upon contact with the ocular surface, which helps to retain moisture and protect against irritants. This gel-like property enhances the stability of the tear film and reduces evaporation, thereby alleviating symptoms associated with dry eye conditions.

Pharmacodynamics

The pharmacodynamic effects of hypromellose are primarily related to its ability to mimic natural tears, providing lubrication to the ocular surface. This lubrication reduces friction during blinking and maintains corneal hydration, which is critical for ocular comfort and health. Its high viscosity also contributes to prolonged retention time on the eye surface.

Pharmacokinetics

Hypromellose is administered topically as eye drops and is not significantly absorbed systemically. The retention time of hypromellose on the ocular surface is enhanced due to its viscosity, allowing for extended relief of dry eye symptoms. The elimination of hypromellose occurs primarily through drainage from the eye and dilution by the natural tear fluid.

Adverse effects

• Temporary visual disturbance
• Eye irritation

Precautions

• Should not be used during contact lens wear
• Use with caution in patients with known hypersensitivity to any component of the formulation

Pregnancy

Hypromellose is generally considered safe for use during pregnancy. However, it should be used only if clearly needed and after consulting a healthcare provider.

Breast-feeding

Hypromellose is unlikely to affect breastfed infants when used as directed, but consultation with a healthcare provider is advisable.

Storage

Store in a cool, dry place away from direct sunlight. Once opened, use within a specified period as indicated on the packaging.

Formulations

• {'name': 'Teardew', 'concentration': '0.3%', 'form': 'eye drops', 'volume': '10 ml'}
• {'name': 'Xailin Hydrate', 'concentration': '0.3%', 'form': 'eye drops', 'volume': '10 ml'}
• {'name': 'AacuLose', 'concentration': '0.3%', 'form': 'eye drops', 'volume': '10 ml'}
• {'name': 'Artelac', 'concentration': '0.32%', 'form': 'eye drops', 'volume': '10 ml'}
• {'name': 'Lacrilube', 'concentration': '2 mg/g', 'form': 'eye ointment', 'volume': '3.5 g'}
• {'name': 'Celluvisc', 'concentration': '1%', 'form': 'eye drops', 'volume': '0.4 ml unit dose'}

Indications

• Bacterial infections
• Urinary tract infections
• Sinusitis
• Uncomplicated community-acquired pneumonia
• Salmonellosis
• Oral infections
• Lyme disease (under expert supervision)
• Acute exacerbation of bronchiectasis
• Anthrax (treatment and post-exposure prophylaxis)

Dosage

Children: 1 month–11 years: 30 mg/kg 3 times a day for 21 days; children 1–4 years: 250 mg 3 times a day; children 5–11 years: 500 mg 3 times a day.

Adults: 500 mg 3 times a day; increased if necessary up to 1 g 3 times a day in severe infections.

Mechanism of action

Amoxicillin works by inhibiting bacterial cell wall synthesis, leading to cell lysis and death. It binds to penicillin-binding proteins (PBPs) located inside the bacterial cell wall, interfering with the transpeptidation process necessary for cell wall integrity.

Pharmacodynamics

Amoxicillin exhibits bactericidal activity against susceptible bacteria. Its action is time-dependent, meaning that its effectiveness is related to the duration of time that the drug concentration remains above the minimum inhibitory concentration (MIC) for the target pathogen.

Pharmacokinetics

Amoxicillin is well absorbed from the gastrointestinal tract, with peak plasma concentrations achieved within 1-2 hours after oral administration. It is widely distributed in body tissues and fluids, and it is excreted primarily via the kidneys. The elimination half-life is approximately 1 hour, and renal impairment may necessitate dosage adjustments.

Adverse effects

• Skin rash
• Gastrointestinal disturbances (nausea, vomiting, diarrhea)
• Allergic reactions (including anaphylaxis)
• Superinfection (due to resistant organisms)

Interactions

• Allopurinol (increases risk of skin rash)

Precautions

• History of penicillin allergy
• Renal impairment (reduce dose)
• Use with caution in patients with mononucleosis

Pregnancy

Use only if clearly needed; no adequate studies in pregnant women.

Breast-feeding

Amoxicillin is excreted in breast milk; use with caution.

Storage

Store in a cool, dry place away from direct sunlight.

Formulations

• Phenoxymethylpenicillin 250mg/5ml oral solution
• Phenoxymethylpenicillin 250 mg tablets

Dosage

Children: Refer to the specific product guidelines for appropriate use, as dosages may vary depending on the product formulation.

Adults: Refer to the specific product guidelines for appropriate use, as dosages may vary depending on the product formulation.

Mechanism of action

Aspartame is metabolized into aspartic acid, phenylalanine, and methanol. These components are then absorbed into the bloodstream and utilized in normal physiological processes, similar to how these amino acids are used when derived from protein-rich foods.

Pharmacodynamics

Aspartame functions as a low-calorie sweetener, providing sweetness without significant caloric contribution. It is composed of naturally occurring amino acids, aspartic acid and phenylalanine, which are utilized by the body in the same way as those derived from dietary proteins. The sweetening effect of aspartame is primarily due to its high sweetness potency compared to sucrose.

Pharmacokinetics

Upon ingestion, aspartame is hydrolyzed in the gastrointestinal tract into its individual components: aspartic acid, phenylalanine, and methanol. These metabolites are then absorbed into the bloodstream. They do not accumulate in the body and are utilized in metabolic processes similar to those of their natural counterparts found in food.

Contra-indications

• Phenylketonuria (PKU)

Adverse effects

• Headaches
• Allergic reactions
• Gastrointestinal disturbances
• Mood changes

Precautions

• Use with caution in individuals with phenylketonuria due to phenylalanine content.

Pregnancy

Considered safe for use during pregnancy, but it is advisable to consult with a healthcare provider.

Breast-feeding

Considered safe for use during breastfeeding, but it is advisable to consult with a healthcare provider.

Storage

Store in a cool, dry place away from direct sunlight.

Formulations

• Tablets
• Powder
• Liquid sweeteners

Indications

• Food coloring
• Flavoring agent
• Culinary applications

Dosage

Children: Refer to food product specifications, as dosage varies based on application. No specific therapeutic dose exists.

Adults: Refer to food product specifications, as dosage varies based on application. No specific therapeutic dose exists.

Mechanism of action

Caramel's mechanism of action primarily involves its role as a colorant and flavor enhancer in food products. The heating process leads to the breakdown of sugar molecules, resulting in the formation of various compounds that contribute to its color and taste. These compounds may also interact with taste receptors, enhancing the sensory experience of food.

Pharmacodynamics

Caramel does not have pharmacological effects in the traditional sense, as it is primarily a food additive. Its primary role is to provide color and flavor to foods rather than exerting therapeutic effects. However, it can influence the palatability of food items, potentially affecting food intake and enjoyment.

Pharmacokinetics

As a food additive, caramel is generally not absorbed in significant quantities in the gastrointestinal tract. It is metabolized by gut bacteria and may be broken down into simple sugars and other metabolites. The exact metabolic pathway is not well defined, as caramel is considered a complex mixture rather than a single compound.

Pregnancy

Caramel is generally regarded as safe for consumption during pregnancy when used in food products.

Breast-feeding

Caramel is considered safe during breastfeeding when consumed in moderate amounts as part of food.

Storage

Store in a cool, dry place, away from direct sunlight.

Formulations

• Liquid caramel
• Caramel powder
• Caramel syrup

Indications

• Bacterial infections caused by beta-lactamase producing organisms
• Community-acquired pneumonia
• Respiratory tract infections
• Urinary tract infections
• Skin and soft tissue infections

Dosage

Children: Paediatric dosing of clavulanate should be determined based on the specific indication and the formulation used. Refer to the BNF for

Adults: The usual adult dose of clavulanate varies depending on the specific antibiotic it is combined with, generally ranging from 125 mg to 250 mg, taken every 8 hours when combined with amoxicillin.

Mechanism of action

Clavulanate works by irreversibly binding to the active site of beta-lactamase enzymes. By inhibiting these enzymes, clavulanate protects beta-lactam antibiotics from degradation, allowing them to exert their antibacterial effects effectively. This mechanism enhances the spectrum of activity of the co-administered antibiotic, thereby improving clinical outcomes in infections caused by beta-lactamase producing organisms.

Pharmacodynamics

Clavulanate exhibits a time-dependent antibacterial effect, characterized by its ability to maintain effective concentrations against beta-lactamase producing bacteria. Its pharmacodynamic properties are mainly influenced by its interaction with beta-lactam antibiotics, enhancing their efficacy in treating infections. The overall effect is a synergistic relationship that increases the potency of the antibiotic treatment.

Pharmacokinetics

Clavulanate is usually administered orally or parenterally, and it is rapidly absorbed from the gastrointestinal tract. It reaches peak plasma concentrations within 1 to 2 hours after administration. The drug is widely distributed in body tissues, with a volume of distribution indicative of good tissue penetration. Clavulanate undergoes hepatic metabolism, primarily by conjugation, and is excreted largely in the urine as metabolites. The elimination half-life is approximately 1 hour, necessitating frequent dosing for optimal therapeutic effect.

Contra-indications

• Hypersensitivity to clavulanate or any component of the formulation
• History of jaundice or hepatic impairment related to previous use of beta-lactam antibiotics

Adverse effects

• Diarrhea
• Nausea
• Vomiting
• Rash
• Hepatic dysfunction
• Allergic reactions

Interactions

• Probenecid may increase concentrations of clavulanate
• Anticoagulants may have altered effects due to changes in gut flora

Precautions

• Monitor liver function during prolonged therapy
• Use cautiously in patients with renal impairment
• Assess for history of allergy to penicillins or cephalosporins

Pregnancy

Clavulanate is classified as category B. Animal studies have not shown teratogenic effects, but adequate and well-controlled studies in pregnant women are lacking.

Breast-feeding

Clavulanate is excreted in breast milk. Caution is advised when administering to nursing mothers.

Storage

Store in a cool, dry place away from direct light. Keep out of reach of children.

Formulations

• Clavulanate potassium 125 mg/5 mL
• Clavulanate potassium 250 mg/5 mL

Indications

• Infections caused by beta-lactamase-producing bacteria
• Acute bacterial sinusitis
• Acute otitis media
• Lower respiratory tract infections
• Urinary tract infections

Dosage

Children: Refer to the BNF for Children for specific dosing according to age and weight; adjustments may be necessary based on the clinical scenario.

Adults: Refer to specific product guidelines for dosing; typical regimens depend on the combination antibiotic used and the severity of the infection.

Mechanism of action

Clavulanic acid works by irreversibly binding to the active site of beta-lactamase enzymes that are produced by certain bacteria to inactivate beta-lactam antibiotics. By inhibiting these enzymes, clavulanic acid protects the penicillin antibiotic from degradation, allowing it to exert its antibacterial effects.

Pharmacodynamics

Clavulanic acid has a synergistic effect when combined with other antibiotics, particularly amoxicillin. The presence of clavulanic acid allows for the effective treatment of infections caused by bacteria that would otherwise be resistant to penicillins. Its antibacterial activity is generally weak on its own but significantly enhances the efficacy of other beta-lactam antibiotics.

Pharmacokinetics

Clavulanic acid is rapidly absorbed after oral administration, with peak plasma concentrations occurring within 1 hour. It is widely distributed throughout the body and has a half-life of approximately 1 hour. The drug is primarily excreted unchanged in the urine. In the presence of renal impairment, dosage adjustment may be necessary, as the elimination of clavulanic acid can be affected.

Contra-indications

• Hypersensitivity to clavulanic acid or any of the excipients
• History of jaundice or hepatic impairment associated with previous use of penicillins or beta-lactam antibiotics

Adverse effects

• Nausea
• Diarrhea
• Rash
• Elevated liver enzymes
• Allergic reactions including anaphylaxis
• Superinfection

Interactions

• May enhance the effects of anticoagulants such as warfarin
• Probenecid may increase plasma concentrations of clavulanic acid
• May reduce the efficacy of oral contraceptives

Precautions

• Caution in patients with renal impairment
• Monitor liver function in patients receiving prolonged therapy
• Use with caution in patients with a history of allergic reactions to beta-lactams

Pregnancy

Clavulanic acid is categorized as pregnancy category B. Animal studies have not shown any harm to the fetus, but there are no adequate and well-controlled studies in pregnant women.

Breast-feeding

Clavulanic acid is excreted in breast milk, but it is generally considered safe for use during breastfeeding. Monitor for potential effects in the infant.

Storage

Store at room temperature, away from moisture and heat. Protect from light. Keep out of reach of children.

Formulations

• Oral tablets
• Oral suspension
• Injectable forms

Indications

• Hypovolemic shock
• Severe burns
• Postoperative fluid replacement
• Sepsis
• Trauma management

Dosage

Children: Refer to established guidelines for specific dosing, as it varies based on the type of colloidal solution used and the clinical condition being treated.

Adults: Refer to established guidelines for specific dosing, as it varies based on the type of colloidal solution used and the clinical condition being treated.

Mechanism of action

Colloidal solutions work by maintaining oncotic pressure in the blood, thus helping to retain fluid within the vascular system. This is primarily due to the large molecular weight of the colloidal particles, which cannot easily pass through capillary walls. The presence of colloids in the blood helps to draw water into the circulation, increasing blood volume and improving tissue perfusion.

Pharmacodynamics

The pharmacodynamics of colloidal solutions are centered on their ability to exert osmotic pressure, which helps maintain blood volume and pressure. This effect is particularly important in conditions such as hypovolemia and shock, where fluid replacement is necessary to restore hemodynamic stability. The efficacy of colloidal solutions can vary depending on the type of colloid used, as well as the underlying clinical condition being treated.

Pharmacokinetics

Colloidal solutions are typically administered intravenously and their pharmacokinetics can vary based on the specific formulation. Generally, colloids are distributed throughout the vascular compartment and have a longer duration of action compared to crystalloids, as they remain in circulation longer. The elimination of colloids is primarily through the reticuloendothelial system, where they are metabolized or eliminated by the liver and spleen. Factors such as particle size and composition can influence their distribution and clearance.

Adverse effects

• Allergic reactions
• Injection site reactions
• Nausea
• Vomiting
• Headache
• Fever

Precautions

• Use with caution in patients with known allergies to any component of the formulation
• Monitor for signs of hypersensitivity during administration
• Consider volume overload in patients with cardiac or renal impairment

Pregnancy

The safety of colloidal solutions during pregnancy has not been established. Use only if the potential benefit justifies the potential risk to the fetus.

Breast-feeding

It is not known whether colloidal solutions are excreted in human milk. Caution should be exercised when administering to breastfeeding mothers.

Storage

Store at room temperature, protect from light, and do not freeze. Keep out of reach of children.

Formulations

• Colloidal silver
• Colloidal gold
• Colloidal iron
• Other metal colloids

Indications

• Monitoring respiratory function
• Assessment of metabolic status
• Management of respiratory acidosis
• Management of respiratory alkalosis

Dosage

Children: Dosing for interventions related to carbon dioxide levels in pediatric patients should be guided by clinical protocols and the BNF for Children.

Adults: Dosing for interventions related to carbon dioxide levels is typically based on clinical assessment and individual patient needs. Refer to clinical guidelines for specific scenarios.

Mechanism of action

Carbon dioxide acts primarily as a signaling molecule in the body, influencing respiratory drive and blood pH. It is produced during cellular respiration and is a critical component of the bicarbonate buffering system, which helps maintain acid-base homeostasis. Elevated levels of CO2 in the blood stimulate ventilation in the lungs, increasing the rate of gas exchange and facilitating the removal of excess CO2.

Pharmacodynamics

The pharmacodynamic effects of dioxides, particularly carbon dioxide, are closely related to its concentration in the blood. As CO2 levels increase, it leads to respiratory acidosis, which can stimulate the respiratory centers in the brain to increase ventilation. Conversely, low levels of CO2 can cause respiratory alkalosis, potentially leading to decreased respiratory drive. CO2 also plays a role in vasodilation and can affect blood flow and pressure through its influence on smooth muscle tone.

Pharmacokinetics

Carbon dioxide is produced endogenously during metabolic processes and is transported in the bloodstream primarily in three forms: dissolved in plasma, as bicarbonate ions (HCO3-), and bound to hemoglobin. The half-life of CO2 in the bloodstream is very short due to its rapid exchange with alveolar gas in the lungs. The elimination of CO2 occurs through exhalation, making it a dynamic component of respiratory physiology.

Pregnancy

Data on the effects of dioxide during pregnancy are limited. Caution is advised due to potential risks associated with exposure.

Breast-feeding

Limited data are available regarding the excretion of dioxide in human milk. Caution is recommended.

Storage

Store in a cool, dry place, away from direct sunlight and moisture.

Indications

• Inflammation
• Pain management
• Antioxidant support
• Potential adjunct in cancer therapy
• Chronic conditions linked to oxidative stress

Dosage

Children: Pediatric dosing for golden-related substances should be determined based on specific formulations and clinical guidelines. Consultation with a healthcare provider is essential to ascertain safe and effective dosing for children

Adults: For golden-related supplements, dosage varies widely depending on the specific formulation and purpose. It is crucial to refer to product-specific guidelines or consult healthcare professionals for appropriate dosing.

Mechanism of action

Compounds often referred to as 'golden', like curcumin, exert their effects primarily through modulation of various signaling pathways. They are known to inhibit pro-inflammatory cytokines and enzymes, such as cyclooxygenase-2 (COX-2) and lipoxygenase. Additionally, they may inhibit the NF-kB pathway, which is critical in regulating the immune response. This leads to a reduction in inflammation and may provide protective effects against chronic diseases.

Pharmacodynamics

The pharmacodynamic properties of golden-related compounds often include anti-inflammatory, antioxidant, and anticancer effects. These compounds can enhance the bioavailability of other drugs and may exhibit synergistic effects when combined with conventional therapies. Their impact on cellular signaling pathways allows them to potentially influence numerous physiological processes, including pain modulation and immune response.

Pharmacokinetics

The pharmacokinetics of golden-related compounds like curcumin involve factors such as absorption, distribution, metabolism, and excretion (ADME). Curcumin is poorly absorbed in the gastrointestinal tract, and its bioavailability is low. It undergoes rapid metabolism in the liver and intestines, leading to the production of various metabolites. The elimination half-life can vary, and food intake can significantly affect absorption rates. Enhanced formulations, such as those with piperine, have been developed to improve bioavailability.

Pregnancy

There is limited data on the safety of golden in pregnancy. Caution is advised, and it should only be used if the potential benefit justifies the potential risk to the fetus.

Breast-feeding

It is not known whether golden is excreted in human milk. Caution is advised when administering to nursing mothers.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Dosage

Children: Refer to BNF for Children for specific recommendations regarding the consumption of orange juice in children.

Adults: There is no standard dosage for orange juice as it is typically consumed as a beverage. Moderation is advised, especially for individuals on certain medications.

Mechanism of action

The exact mechanism of action of orange juice is not fully understood, but it is known to contain compounds that can influence the metabolism of certain drugs. For instance, it may affect the activity of cytochrome P450 enzymes, particularly CYP3A4, which can alter the pharmacokinetics of medications.

Pharmacodynamics

Orange juice is known to enhance the bioavailability of certain nutrients and may influence the pharmacological effects of some drugs. Its high vitamin C content contributes to various physiological functions, including antioxidant activity, which may indirectly support overall health.

Pharmacokinetics

The pharmacokinetics of orange juice itself are not extensively studied, but it is generally absorbed well through the gastrointestinal tract. The compounds in orange juice can affect the absorption and metabolism of medications, leading to varied clinical effects depending on the drug in question.

Interactions

• orange juice + celiprolol: Unknown (decreases exposure)

Formulations

• juice
• whole fruit

Indications

• Digestive aid
• Anti-inflammatory treatment
• Support for wound healing
• Sinusitis relief
• Potential adjunct in cardiovascular health

Dosage

Children: Pediatric dosing for bromelain is not well established. It is important to consult with a healthcare professional for appropriate dosing in children.

Adults: The typical dosage of bromelain supplements varies, but is often in the range of 200 to 400 mg taken 2 to 3 times daily. It is advisable to refer to specific product labels and consult healthcare professionals for personalized dosing recommendations.

Mechanism of action

Bromelain, the primary active compound in pineapple, exerts its effects by breaking down proteins into amino acids and peptides. This proteolytic activity is thought to facilitate digestion and reduce inflammation. Additionally, bromelain may enhance the absorption of certain antibiotics and other medications by improving gastrointestinal tract conditions.

Pharmacodynamics

Bromelain has shown anti-inflammatory, analgesic, and antithrombotic effects. It may modulate immune responses, reduce swelling, and promote healing. The pharmacodynamic properties of pineapple are largely attributed to bromelain, which acts on various pathways, including the modulation of cytokine production and inhibition of pro-inflammatory mediators.

Pharmacokinetics

Bromelain is rapidly absorbed in the gastrointestinal tract following oral administration. The bioavailability of bromelain can be affected by food intake, with some studies suggesting that it is best absorbed on an empty stomach. The elimination half-life is not well-defined, but its effects can persist due to its interactions with various biological pathways.

Adverse effects

• Allergic reactions in sensitive individuals
• Diarrhea
• Nausea
• Abdominal pain
• Heartburn

Interactions

• May interact with anticoagulants due to bromelain content
• Potential interaction with certain antibiotics
• Can affect the metabolism of some drugs due to effects on cytochrome P450 enzymes

Precautions

• Use with caution in individuals with known allergies to pineapple or bromelain
• Should be used cautiously in individuals with gastrointestinal disorders
• Consider potential interactions with anticoagulant medications

Pregnancy

Generally considered safe in food amounts, but high doses or supplements should be avoided due to potential uterine contractions.

Breast-feeding

Likely safe in food amounts; however, high doses or supplements should be avoided as effects are not well studied.

Storage

Store in a cool, dry place away from direct sunlight. Fresh pineapple should be refrigerated and consumed promptly.

Formulations

• Fresh pineapple
• Canned pineapple
• Pineapple juice
• Bromelain supplements

Indications

• Antioxidant support
• Anti-inflammatory effects
• Potential cancer prevention
• Support for cardiovascular health
• Glycemic control

Dosage

Children: Refer to specific dietary guidelines. No standard therapeutic dose established.

Adults: Refer to specific dietary guidelines. No standard therapeutic dose established.

Mechanism of action

The bioactive compounds in raspberries, such as ellagic acid, quercetin, and anthocyanins, exert their effects through various mechanisms. They are known to scavenge free radicals, modulate cell signaling pathways, and influence gene expression related to inflammation and cancer progression. These compounds may also enhance the activity of certain detoxifying enzymes in the body.

Pharmacodynamics

Raspberry exhibits antioxidant activity, which helps protect cells from oxidative stress and damage caused by free radicals. The anti-inflammatory properties are attributed to the inhibition of pro-inflammatory cytokines and enzymes, thereby reducing inflammation. Additionally, some studies suggest that components of raspberry may influence lipid metabolism and improve glycemic control.

Pharmacokinetics

The bioactive compounds in raspberries are subject to digestion and metabolism, with absorption occurring primarily in the intestine. The specific pharmacokinetics of raspberry compounds can vary based on the individual compound, but generally, they are rapidly absorbed and can be detected in plasma shortly after consumption. The half-life of these compounds can vary significantly depending on the specific component and individual metabolic factors.

Adverse effects

• Allergic reactions
• Gastrointestinal upset
• Diarrhea

Precautions

• Use with caution in individuals with known allergies to berries.
• Consult a healthcare provider before use in patients with diabetes due to potential effects on blood sugar levels.

Pregnancy

Raspberries are generally considered safe during pregnancy when consumed in moderate amounts as part of a healthy diet.

Breast-feeding

Raspberries are safe to consume while breastfeeding, but excessive intake should be avoided.

Storage

Store in a cool, dry place. Fresh raspberries should be refrigerated and consumed within a few days.

Formulations

• Fresh raspberries
• Dried raspberries
• Raspberry extract
• Raspberry juice

Indications

• Potential role in bone health
• Support for connective tissue formation
• May aid in mineral metabolism

Dosage

Children: There is no established clinical dosage for silicon in paediatric populations, as it is not classified as an essential nutrient.

Adults: There is no established clinical dosage for silicon in adults, as it is not classified as an essential nutrient.

Mechanism of action

Silicon is believed to enhance the synthesis of glycosaminoglycans and collagen, which are important for the structural integrity of connective tissues. It may also influence the activity of certain enzymes involved in bone mineralization, thus playing a role in maintaining bone density and health.

Pharmacodynamics

The pharmacodynamics of silicon is not fully elucidated; however, it is thought to involve the modulation of bone metabolism and the promotion of connective tissue health. Silicon may have a synergistic effect with other minerals, such as calcium and magnesium, aiding in their utilization and metabolism in the body.

Pharmacokinetics

The pharmacokinetics of silicon is complex, as it is not absorbed through typical gastrointestinal pathways. Instead, silicon is thought to be taken up in the form of silicates and then distributed throughout the body, particularly in connective tissues. The elimination of silicon occurs primarily through renal excretion, with some variations depending on dietary intake and individual metabolism.

Pregnancy

Silicon is generally considered safe during pregnancy, as it is a naturally occurring element in the human body. However, specific recommendations regarding supplementation should be followed based on the advice of a healthcare provider.

Breast-feeding

Silicon is present in breast milk in small amounts. Its safety during breastfeeding is generally regarded as acceptable, although supplementation should be approached with caution and under medical advice.

Storage

Silicon should be stored in a cool, dry place, protected from light and moisture. Follow specific storage recommendations provided by the manufacturer if available.

Indications

• Energy metabolism disorders
• Neuroprotection
• Potential adjunct therapy in mitochondrial dysfunction
• Investigational uses in ischemic conditions

Dosage

Children: Refer to specific guidelines and clinical recommendations for paediatric dosing as it may vary based on the therapeutic context.

Adults: Refer to specific guidelines and clinical recommendations for adult dosing as it may vary based on the therapeutic context.

Mechanism of action

Succinic acid acts primarily as a substrate in the citric acid cycle, where it is converted to fumarate by the enzyme succinate dehydrogenase. This reaction is part of the electron transport chain, which is vital for ATP production. Additionally, succinic acid can influence cellular signaling pathways, contributing to the regulation of mitochondrial function and energy homeostasis. It also has effects on GABA receptors, which may modulate neuronal excitability and contribute to its neuroprotective properties.

Pharmacodynamics

The pharmacological effects of succinic acid are related to its role in metabolism and energy production. By participating in the citric acid cycle, it helps maintain the balance of energy substrates in cells. Succinic acid may also have antioxidant properties, reducing oxidative stress and mitigating cellular damage. In the context of neuroprotection, it may enhance neuronal survival in conditions of hypoxia or ischemia.

Pharmacokinetics

Succinic acid is rapidly absorbed from the gastrointestinal tract and distributed throughout the body. It is metabolized in the liver and can be converted to various metabolites that enter the citric acid cycle. The elimination of succinic acid occurs primarily through renal excretion. The half-life and specific pharmacokinetic parameters may vary based on the formulation and method of administration.

Pregnancy

There is limited information on the safety of succinic acid during pregnancy. Consult healthcare professionals before use.

Breast-feeding

It is not known whether succinic acid is excreted in human milk. Caution is advised.

Storage

Store in a cool, dry place, away from direct sunlight. Keep out of reach of children.

Indications

• Used as a thickening agent in food products
• Utilized in pharmaceutical formulations as a stabilizer
• Employed in cosmetics for texture improvement
• Applied in industrial products for its viscosity properties

Dosage

Children: Refer to specific product guidelines for appropriate use. Xanthan is used in formulations as a thickener or stabilizer, and dosage should be evaluated based on the specific product and formulation.

Adults: Refer to specific product guidelines for appropriate use. Xanthan is typically used in small quantities as a thickener or stabilizer in food and pharmaceutical products.

Mechanism of action

Xanthan functions primarily as a thickener and stabilizer. It acts by interacting with water molecules to form a gel-like consistency, which enhances the texture and stability of products. Its unique rheological properties allow it to maintain viscosity under varying conditions, which is beneficial in food and pharmaceutical applications.

Pharmacodynamics

Xanthan's action is primarily physical rather than pharmacological. It does not exert a direct therapeutic effect but influences the delivery and stability of active ingredients in formulations. The gel formation and viscosity changes help ensure the uniform distribution of substances in liquid formulations, which can improve the effectiveness of the drug delivery.

Pharmacokinetics

As xanthan is a polysaccharide, it is not absorbed in the gastrointestinal tract when ingested. It passes through the digestive system largely unchanged. In terms of metabolism, xanthan is broken down by colonic bacteria, resulting in short-chain fatty acids. Its pharmacokinetic profile indicates that it has a low bioavailability due to its large molecular size and structure.

Pregnancy

There is insufficient data on the use of xanthan during pregnancy. Consult a healthcare professional before use.

Breast-feeding

There is insufficient data on the excretion of xanthan in human milk. Consult a healthcare professional before use.

Storage

Store in a cool, dry place, away from direct sunlight.

Formulations

• Xanthan gum powder

Mechanism of action

Amoxicillin competitively inhibits penicillin-binding protein 1 and other high molecular weight penicillin binding proteins. Penicillin bind proteins are responsible for glycosyltransferase and transpeptidase reactions that lead to cross-linking of D-alanine and D-aspartic acid in bacterial cell walls. Without the action of penicillin binding proteins, bacteria upregulate autolytic enzymes and are unable to build and repair the cell wall, leading to bacteriocidal action. The penicillins and their metabolites are potent immunogens because of their ability to combine with proteins and act as haptens for acute antibody-mediated reactions. The most frequent (about 95 percent) or "major" determinant of penicillin allergy is the penicilloyl determinant produced by opening the beta-lactam ring of the penicillin. This allows linkage of the penicillin to protein at the amide group. "Minor" determinants (less frequent) are the other metabolites formed, including native penicillin and penicilloic acids. /Penicillins/ Amoxicillin is similar to penicillin in its bactericidal action against susceptible bacteria during the stage of active multiplication. It acts through the inhibition of cell wall biosynthesis that leads to the death of the bacteria.

Pharmacodynamics

Amoxicillin competitively inhibit penicillin binding proteins, leading to upregulation of autolytic enzymes and inhibition of cell wall synthesis. Amoxicillin has a long duration of action as it is usually given twice daily. Amoxicillin has a wide therapeutic range as mild overdoses are not associated with significant toxicity. Patients should be counselled regarding the risk of anaphylaxis, _Clostridium difficile_ infections, and bacterial resistance.

Mechanism of action

180 to 200 times sweeter than sucrose, it is metabolized as a protein and its subsequent amino-acids used up in there respective mechanisms.

Pharmacodynamics

Aspartame (L-alpha-aspartyl-L-phenylalanine methyl ester) is a low-calorie sweetener used to sweeten a wide variety of low- and reduced-calorie foods and beverages, including low-calorie tabletop sweeteners. Aspartame is composed of two amino acids, aspartic acid and phenylalanine, as the methyl ester. Aspartic acid and phenylalanine are also found naturally in protein containing foods, including meats, grains and dairy products. Methyl esters are also found naturally in many foods such as fruits and vegetable and their juices. Upon digestion, aspartame breaks down into three components (aspartic acid, phenylalanine and methanol), which are then absorbed into the blood and used in normal body processes. Neither aspartame nor its components accumulates in the body. These components are used in the body in the same ways as when they are derived from common foods.